Organisation · Unternehmen
Aeon Respire
aeon-respire-eutr-39180957
· GB
Aussagen (8)
eu transparency category
Companies & groups
dokumentiert
[Q-16056]
eu transparency goals
Development of a novel inhaled therapy to treat respiratory disease.
dokumentiert
[Q-16056]
eu transparency id
282090391809-57
dokumentiert
[Q-16056]
headquarters city
Newbury Park
dokumentiert
[Q-16056]
headquarters country
GB
dokumentiert
[Q-16056]
interest class
business_company
dokumentiert
[Q-29773]
legal form
Inc., US corporation
dokumentiert
[Q-16056]
legal form class
ausland_sonstig
berichtet
[Q-29773]